Recruiting Cardiomyopathy Studies in Miami
Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy
The purpose of this study is to evaluate the safety and effectiveness of an experimental drug called human allogeneic mesenchymal stem cell therapy....
A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).
The purpose of this study is to evaluate the efficacy, safety and PK of aficamten in a pediatric population with symptomatic obstructive hypertrophic cardiomyopathy (oHCM)....
About Cardiomyopathy Clinical Trials in Miami
Cardiomyopathy refers to diseases of the heart muscle that make it harder for the heart to pump blood. Types include dilated, hypertrophic, and restrictive cardiomyopathy. Treatment depends on the type and may include medications, devices, or heart transplant.
There are currently 2 cardiomyopathy clinical trials recruiting participants in Miami, FL. These studies are seeking a combined 176 participants. Research is being sponsored by Joshua M Hare, Cytokinetics. Clinical trial participation is free and participants receive study-related medical care at no cost.
Cardiomyopathy Clinical Trials in Miami — FAQ
Are there cardiomyopathy clinical trials in Miami?
Yes, there are 2 cardiomyopathy clinical trials currently recruiting in Miami, FL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Miami?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Miami research site will contact you about next steps.
Are clinical trials in Miami free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Miami studies also compensate for your time and travel.
What cardiomyopathy treatments are being tested?
The 2 active trials in Miami are testing new therapies including novel drugs, biologics, and treatment approaches for cardiomyopathy.
Data updated March 2, 2026 from ClinicalTrials.gov